British Pharmacological Society/The Physiological Society--joint meeting. Advances in glutamatergic pharmacology.
As befits the coming together of two major national societies, the Bristol meeting attracted a significant array of eminent pharmacologists and physiologists. This was reflected in the presentation of over 350 poster and oral communications stretching over the 3 days, with the host institution contributing substantially to the proceedings. A significant number of communications relating to glutamatergic transmission were presented, which will be the focus of this review. New information was disclosed relating to a novel class of metabotropic glutamate receptor modulators, recent advances in Glu(K5) compounds, AMPA/kainate and AMPA/NMDA receptor discriminators, and NMDA receptor subtype-selective compounds. Disclosures pertain to therapeutic areas including epilepsy, Parkinson's disease, cognitive enhancement, analgesia and psychosis.